Search results
Results from the WOW.Com Content Network
In 2005, Abiomed purchased ventricular assist device company Impella CardioSystems AG of Aachen, Germany, [11] maker of the Impella heart pump, developed by Thorsten Siess, [12] who is now the chief technology officer at Abiomed. [13] [self-published source] After Abiomed acquired Impella the company's focus shifted from heart replacement to ...
Thoratec was the first company to gain approval of a VAD for permanent use in patients too ill for a heart transplant. [5] The company introduced an enhanced version of the device, the HeartMate XVE, and it was FDA approved for destination therapy in May 2003, having previously been approved for bridge to transplantation. [15]
[13] [14] [15] In some pulsatile pumps (that use compressed air as an energy source [16]), the volume occupied by blood varies during the pumping cycle. If the pump is contained inside the body then a vent tube to the outside air is required. Continuous-flow VADs are smaller and have proven to be more durable than pulsatile VADs. [17]
The pumps, left-sided Impella heart pumps made by Johnson & Johnson MedTech’s Abiomed, have been linked to more than 100 serious injuries, including 49 deaths.
For premium support please call: 800-290-4726 more ways to reach us
Medical device maker Abiomed Inc said on Tuesday the U.S. Food and Drug Administration granted its left-sided heart pumps emergency use authorization to help patients suffering from COVID-19 ...
Impella heart pumps are percutaneous microaxial pumps that act as mechanical circulatory support devices in patients in need of hemodynamic support. [11] The pumps are mounted on support catheters and typically inserted through the femoral artery , although axillary and subclavian artery approaches are not uncommon.
(Reuters) -Johnson & Johnson on Friday agreed to buy Shockwave Medical in a deal valued at $13.1 billion including debt, as it builds its cardiac-health-centric medical devices business to help ...